How do APR and PQR differ in terms of the number of batches to be assessed in the review period?

12.09.2022

Question of the Week

While all batches have to be checked for the specified issues in the EU GMP Guide for the PQR, 21 CFR 211.180(e) requires a representative number of batches for the APR. There is however also a requirement to ensure that changes or irregularities are taken into account.

[GMP Compliance Adviser, Chapter 1.J]

Would you like to discover more?

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

EMA: New Q&A on Product Lifecycle Management (PLCM)

30.01.2026

News

EMA: New Q&A on Product Lifecycle Management (PLCM)

The EMA has published new Questions & Answers on the use of the Product Lifecycle Management (PLCM) document, clarifying its role within the EU variations framework for post-approval quality changes.

EMA: New Q&A for Co-Processed Excipients

The EMA has published new Questions & Answers on co-processed excipients (CoPEs) used in solid oral dosage forms, introducing a harmonised, risk-based regulatory approach applicable to human and veterinary medicines.

What is the Data Lifecycle?

Here's the answer: